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The efficiency of viruses in cancer therapy is enhanced by proteins that mediate the fusion of infected cells
with their neighbors. It was reported that replication-competent adenovirus particles can spread between
nuclei within fusion-generated syncytia. To assess this conjecture, we generated fusogenic adenoviruses that
express a balanced ratio of the F and H glycoproteins of measles virus. The viruses displayed enhanced
cytotoxicity but largely unchanged replication efficiencies compared to a nonfusogenic virus. Most notably, the
virus genomes did not spread through fusion-generated multinuclear cells. Hence, adenovirus replication in
syncytia remains largely restricted to initially transduced nuclei.
As a tool for cancer therapy, adenoviruses are being engi-
neered to replicate in tumor cells, thus enhancing their thera-
peutic effect by multiple rounds of infection (2, 4, 8). An at-
tractive strategy for obtaining “armed” therapeutic viruses
(18–20) consists of the expression of fusogenic proteins that
lead to the fusion of infected cells with adjacent cells, thereby
increasing the toxicity of the viruses (3, 22). Fusogenic proteins
are typically derived from enveloped viruses that use them to
fuse membranes and penetrate cells. Such proteins from hu-
man immunodeficiency virus type 1 or from measles virus have
been inserted into the adenovirus genome (1, 14, 24, 27).
Fusogenic recombinant adenoviruses obtained in this way
spread more efficiently through tumor xenografts. This raises
the possibility that viral DNAs can spread between nuclei
within syncytia formed by cell fusion. In particular, one report
documented the existence of viral particles in multiple nuclei
and suggested that DNA replication can occur in many nuclei
of a syncytium (24). Potentially, this internuclear adenoviral
DNA spread might strongly enhance infection efficiency. How-
ever, it is not clear how adenoviral DNA can efficiently enter
nuclei if the newly synthesized particles do not leave their host
cell and enter another cell to undergo standard maturation
steps (36, 37). This raises the following fundamental question
concerning the biology of adenovirus replication. Are virus
release and reuptake necessary for the delivery of viral DNA to
the nucleus and for its subsequent replication?
Fusogenic adenovirus. To create a fusogenic recombinant
adenovirus, we inserted a bicistronic expression cassette for
measles virus glycoproteins F and H to replace the E1 gene
region within the plasmid pAdEasy1 (21), which contains the
other essential regions of the adenovirus genome (Fig. 1A). To
drive the expression of F and H, we used either the major
immediate early promoter of cytomegalovirus (CMV pro-
moter) or the adenovirus major late promoter (MLP). The
mRNA consisted of the coding region for H followed by the
encephalomyocarditis virus internal ribosomal entry site
(IRES) and the F coding region. All viruses were rescued by
use of a plasmid-based AdEasy system (21), and Ad CMV
Gal, which was used as a control, was described previously
(23). Our cloning strategies are available upon request. When
transfected into E1-complementing HER911 cells (12), the
plasmid containing the CMV F&H cassette induced extensive
cell fusion, which was visualized by the use of green fluorescent
protein (GFP) expressed by the same plasmid (Fig. 1B, a). The
addition of fusion inhibitory peptide (FIP) virtually abolished
cell fusion (Fig. 1B, b), in agreement with results obtained in
the context of measles virus infection (29, 33). When F and H
expression was put under the control of the adenovirus MLP,
the transfected cells fused much less efficiently, if at all, re-
gardless of the presence or absence of FIP (Fig. 1B, c and d).
This was expected, since the MLP reaches its full activity only
at the late stage of adenovirus infection (25, 36). Ten days after
transfection in the presence or absence of FIP, the cells were
harvested and the virus yield was determined. When fusion was
allowed, the amount of rescued virus was about 10-fold lower
than that when it was inhibited by FIP (Fig. 1C), possibly
explaining previous difficulties in the construction of fusogenic
adenoviruses (14). Thus, the use of a fusion inhibitory peptide
or the expression of fusogenic gene products only in the late
phase can each increase the efficacy of virus rescue.
Cytotoxicity. When HER911 cells were infected with Ad
CMV F&H at a low multiplicity of infection (MOI), large
syncytia formed around infected cells (Fig. 2A), whereas no
such phenomenon was observed when we used a virus express-
ing beta-galactosidase instead of the measles virus glycopro-
teins. At a high MOI, cells infected with the fusogenic adeno-
virus formed large spheric syncytia that detached from the
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solid support, an effect that was inhibited by the addition of
FIP (data not shown). When F and H cDNAs were expressed
from the adenovirus major late promoter, fusion was delayed
but eventually occurred at a similar extent as that with Ad
CMV F&H (Fig. 2A). The overall cytotoxicity of fusogenic
adenoviruses was assessed by infecting HER911 cells. At var-
ious time points, detached cells were washed off, and adherent
cells were stained with crystal violet. Ad CMV F&H as well as
Ad MLP F&H displayed cytotoxicity at earlier time points than
did a nonfusogenic virus (Fig. 2B). The addition of FIP de-
creased the cytotoxicity (data not shown). We concluded that
the expression of fusogenic proteins can enhance the cytotox-
icity of a replicating adenovirus.
Virus replication. HER911 cells were infected with Ad
CMV F&H or an otherwise identical virus that expressed beta-
galactosidase (Ad CMV Gal), followed by determinations of
FIG. 1. Improving the yield of recombinant fusogenic adenovirus by use of FIP or by late expression of fusogenic proteins. (A) Schematic
presentation of fusogenic adenoviruses (linear genomes). Vector genomes are depicted and indicate the assembly of the transgene. The virus
genome starts with the left inverted terminal repeat region (LITR) and the encapsidation signal (ES). The positions of some of the early (E) and
late (L) genes are indicated. The promoters used to express F and H were either the cytomegalovirus major immediate early promoter (CMV)
or the adenovirus major late promoter (MLP). The genes encoding the H and F genes of measles virus (strain Edmonston) were separated by the
IRES of encephalomyocarditis virus. A polyadenylation signal (polyA) was then followed by a CMV promoter-driven expression cassette for GFP.
(B) Cell morphology upon transfection of GFP-expressing virus genomes. HER911 cells were transfected (Lipofectamine Plus; Invitrogen) with
linearized plasmids containing the virus genomes shown in panel A. FIP was added as indicated. After 48 h, green fluorescence was monitored by
microscopy. (C) Virus yield 10 days after transfection, given in fluorescence-forming units (f.f.u.) per ml of cell lysate. HER911 cells were trans-
fected and treated as described for panel B. After 10 days, the emerged virus was harvested and quantified on a fresh monolayer of HER911 cells
as described previously (23, 40). The average titers of at least three independent experiments are shown along with standard errors. The left two
columns reflect results obtained in the absence of FIP; the right two columns show the titers obtained in the presence of FIP.
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virus yields. As shown in Fig. 3A, virus particle production was
not measurably affected by the expression of fusogenic proteins
or by the addition of FIP. Similar results were obtained with
another cell line, H1299, by the use of combinations of vector
and wild-type viruses (data not shown). Upon infection of
HER911 cells with fusogenic or nonfusogenic viruses, the lev-
els of viral proteins were assessed by immunoblot analysis as
described previously (34). Antibodies were directed against
adenovirus E2A (B6-8 [32]) (obtained from J. Flint), the ade-
novirus hexon protein (goat polyclonal antibody) (Biogenesis),
and E4orf6 (M45) (kindly provided by P. Hearing). As shown
in Fig. 3B, the expression levels of all proteins were similar
between the viruses, regardless of the ability to induce cell fu-
sion. The same was found for viral DNAs, as revealed by semi-
quantitative PCRs (Fig. 3C). We concluded that cell fusion nei-
ther enhances nor reduces the efficiency of virus replication.
Replication centers within syncytia. The failure of cell fu-
sion to enhance the efficiency of virus replication contrasted
with the previous suggestion that adenoviruses spread between
the nuclei of a syncytium, thereby enhancing replication (24).
Since fusogenic adenoviruses provide a unique opportunity to
determine whether virus entry and the associated maturation
process are essential for the subsequent steps of the viral life
cycle, we reexamined the issue of secondary virus replication in
nuclei of cells that had fused with an originally infected cell. To
this end, we infected HER911 cells with the fusogenic adeno-
virus at a low MOI. To avoid reinfection, we added a neutral-
izing antibody (clone 1D6;14, an anti-fiber knob antibody [10])
(kindly provided by J. Douglas) at a neutralizing concentration
3 h after the addition of the virus. At 48 h postinfection, the
intracellular localization of the E2A 72-kDa DNA binding pro-
tein was determined by immunofluorescence as described pre-
viously (34). During adenovirus infection, this protein initially
localizes in a diffuse nuclear pattern but then associates with
replicating viral DNAs in discrete nuclear foci termed replica-
tion centers (30). Syncytia were detected by their characteristic
FIG. 2. Cytotoxicity induced by fusogenic adenovirus. (A) Timing of fusion. HER911 cells were infected with the indicated virus preparations
at an MOI of 0.01 for the indicated times, followed by monitoring of the distribution of GFP by fluorescence microscopy. (B) Time course of
cytotoxic effects. HER911 cells were transduced with the indicated viruses (MOI  1) for the indicated times. Subsequently, detached cells were
washed off the plate, and the remaining cell monolayer was stained with crystal violet.
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distribution of GFP (Fig. 4A, a). We found that the majority of
the nuclei within syncytia (visualized by DAPI staining) (Fig.
4A, b) contained readily detectable E2A 72-kDa protein (Fig.
4A, c). However, only one of these nuclei typically displayed
the characteristic distribution of the E2A 72-kDa protein in
nuclear foci, suggesting that only one nucleus contained repli-
cating viral DNA (Fig. 4A, c).
To assess more rigorously the ability of viral DNA to spread
between nuclei, we performed similar infection experiments,
followed by the detection of viral DNA by fluorescent in situ
hybridization (FISH) as described previously (13). All nuclei
within a syncytium were detected by DAPI (4,6-diamidino-2-
phenylindole) staining (Fig. 4B, a), and E2A-72 kDa was im-
munostained (Fig. 4B, b). As shown in Fig. 4B, c, only one
nucleus within a syncytium typically contained detectable viral
DNA.
The presence of viral DNA was evaluated in many syncytia
at 24 and 48 h postinfection (Fig. 4C and D). Almost all nuclei
within a given syncytium were positive for E2A, whereas only
one or a few of them contained viral DNA. We propose that
only occasionally, independently infected cells became incor-
porated into the same syncytium, thereby creating syncytia with
more than one nucleus harboring viral DNA. In conclusion, ade-
novirus DNA does not normally undergo internuclear spread-
ing upon fusion of an infected cell with uninfected neighboring
cells.
These findings are in apparent contrast with the detection by
electron microscopy of adenovirus particles in virtually all nu-
clei of a syncytium (24). However, considering that empty
FIG. 4. Formation of replication centers within syncytia. HER911 cells were infected at an MOI of 0.01 with Ad CMV F&H. To avoid
extracellular spread, we added an antibody against the fiber knob 3 h after infection. After 48 h, immunostaining of the E2A 72-kDa DNA-binding
protein was performed. (A) GFP distribution (a) and DAPI staining (to visualize all nuclei) (b) were monitored, and E2A was visualized by
immunofluorescence (c). The typical distribution of E2A in replication centers (RC) within one of the nuclei is indicated by an arrow. (B) The total
DNA was stained with DAPI (a), and E2A-72 kDa was visualized by immunofluorescence (b). In addition, viral DNA was stained by FISH (c).
Superimposed patterns of E2A and viral DNA are shown in panel d. At least 30 syncytia were evaluated at 24 (C) or 48 (D) h postinfection by
FISH and immunostaining. The total number of nuclei within each syncytium was plotted against the number of E2A-positive nuclei (black dots)
and against the number of cell nuclei that stained positive for viral DNA (gray dots). (E) To monitor hexon assembly, we transduced HER911 cells
as described above and then added an antibody against the fiber knob. After 48 h, immunostaining of the hexon protein was performed (b). The
cells were also stained with DAPI to detect all nuclei (a), and FISH was employed to detect viral DNA (c). The patterns of hexon and viral DNA
were superimposed (d). (F) To study the formation of replication centers in preformed syncytia, we transfected 911 cells with an expression plasmid
for the measles virus F and H proteins. After 24 h, syncytia had formed, and further fusion was stopped by the addition of FIP. The cells were then
infected with the wild-type adenovirus dl309, followed by incubation for another 24 h. E2A was then stained as described for panel A. (G) U2OS
cells seeded at a low density were coinfected with wild-type adenovirus dl309 and Ad CMV F&H at an MOI of 10. Three hours later, fresh U2OS
cells were added to form a confluent monolayer, and an antibody against the fiber knob was added. Forty-eight hours later, the cells were fixed
and E2A was stained as described for panel A.
FIG. 3. Replication yield of fusogenic adenovirus. (A) Replication
in the presence or absence of fusion. HER911 cells were infected with
the indicated virus preparations. At 48 h postinfection, the viruses were
harvested and titrated. (B) HER911 cells were infected as indicated
(MOI  0.1). The expression of the viral gene products E2A, E4orf6,
and hexon was monitored by immunoblotting 48 h after infection.
Lamin was stained as an input control. (C) Upon infection as described
for panel B, the amounts of viral DNA were determined at the indi-
cated times postinfection by semiquantitative PCRs with the indicated
numbers of PCR cycles in the presence or absence of FIP. The PCR
products were visualized by ethidium bromide staining after agarose
gel electrophoresis.
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particles can hardly be distinguished from DNA-containing
viruses by electron microscopy and that the hexon protein is an
essential component of both viruses and empty particles, we
determined which nuclei contained this protein. Since the
hexon protein was detectable in virtually all nuclei of the syn-
cytia (diffusely or in discrete clusters [Fig. 4E]), we suggest that
empty particles may have been confused with infectious viruses
by electron microscopy.
To verify whether the nuclei of a syncytium can support virus
replication if they are reached by infectious particles, we in-
fected preformed syncytia with viruses. HER911 cells were
transiently transfected with an expression plasmid for F and H.
After syncytium formation, fusion progression was blocked by
the addition of FIP. The preformed syncytia were then infected
with wild-type adenovirus, and the formation of replication
centers was monitored by immunostaining of E2A-72 kDa. As
shown in Fig. 4F, virtually all nuclei of the preformed syncytia
contained replication centers, indicating that the previously
observed lack of internuclear spread was not due to a general
defect of intrasyncytial nuclei to support the replication of viral
DNA.
In the experiments described above, the E1 gene products
were provided by integrated E1 regions within the chromo-
somes of the host cells. To test whether this influenced the
internuclear spread of virus replication, we coinfected U2OS
cells with a wild-type adenovirus, dl309, and with Ad CMV F&H.
These cells were then allowed to fuse with uninfected cells,
followed by immunostaining of E2A-72 kDa. As shown in Fig.
4G, the syncytia obtained in this way still contained just one
nucleus with replication centers, strongly arguing that virus ge-
nomes do not spread, regardless of the origin of E1 gene prod-
ucts.
Fusogenic viruses in cancer therapy. Replication-compe-
tent, fusogenic adenoviruses reduce tumor xenografts more
efficiently than do their parental viruses (1). Previous results
suggested three favorable properties of fusogenic adenovi-
ruses, i.e., a lateral spread of transgenes, a dispersion of viruses
to cells that were not initially infected, and a more rapid re-
lease of virus (24). The experiments reported here challenge
only the second of these points but do not shed doubts on the
other two. Thus, even if viral DNA does not efficiently spread
between nuclei within a syncytium, cell fusion remains a viable
strategy for increasing the oncolytic efficiency of replicating
adenoviruses. It is important that the measles virus H protein
can be retargeted; different measles virus strains bind the ubiq-
uitously expressed CD46 molecule and the signaling lympho-
cyte activation molecule (6, 9, 11, 35, 38). However, the H
protein residues interacting with natural receptors modified
the protein (39) and single-chain antibodies specific for surface
proteins preferentially expressed by tumor cells can be added
to it, enabling antibody-targeted cell fusion (5, 17, 27, 31).
Virus release and reuptake are essential steps of the repli-
cation cycle. The direct detection of viral DNAs by FISH in
this study revealed that after being formed in one nucleus
within a multinuclear cell, virus particles do not leave it to
infect adjacent nuclei, in contrast to a previous suggestion (24).
The previous report employed human immunodeficiency virus
gp120 and CD4 receptors for fusion with a self-replicating
virus, and we cannot formally rule out the possibility that the
internuclear spread of genomes might be dependent on the
receptors used to induce fusion. However, our results are con-
sistent with the current notion that newly formed virus parti-
cles that escape from infected cells (usually by lysis) and start
a new infectious cycle must undergo a precisely orchestrated
program of dismantling and intracellular transport following
cell entry in order to efficiently inject their DNA into the
nucleus. Processing occurs within compartments that cannot
be reached by a virus without its leaving the cell and entering
a new one. Once the virus binds to its receptor molecules, a
coated pit is formed below the cell surface before a coated
vesicle moves into the cell. During this early phase of infection,
the fibers are lost (28). Additional structural changes within
the virus particles include the dissociation of the penton base,
the degradation of the proteins that connect the DNA to the
inside surface of the capsid, and the elimination of the capsid-
stabilizing minor proteins (16). A protease activation step in
the acidic environment of endosomes is needed for the nuclear
uptake of viral DNA (15, 16). These processing steps occur
along a predetermined pathway including coated vesicles and
the endosome, passing through the cytosol along microtubules,
and reaching the nuclear pore complex, where the viral DNA
is released into the nucleus (7, 26). Our results indicate that
efficient adenovirus replication cannot occur without extracel-
lular particle spread.
We thank H.-D. Klenk and R. Arnold for continuous support. We
are indebted to J. Douglas, J. Flint, A. J. Levine, A. Maisner, M. Moll,
J. Roth, T. Shenk, and B. Vogelstein for their generous gifts of plas-
mids, antibodies, viruses, and cells and for helpful discussions.
Our work was supported by the German Research Foundation
(DFG), the Deutsche Krebshilfe/Dr. Mildred Scheel Stiftung, and the
P.E. Kempkes Stiftung. G.P.H. gratefully acknowledges support by a
stipend from the Fazit Foundation, and R.C. acknowledges funding by
NIH grant CA90636.
REFERENCES
1. Ahmed, A., D. Jevremovic, K. Suzuki, T. Kottke, J. Thompson, S. Emery, K.
Harrington, A. Bateman, and R. Vile. 2003. Intratumoral expression of a
fusogenic membrane glycoprotein enhances the efficacy of replicating ade-
novirus therapy. Gene Ther. 10:1663–1671.
2. Alemany, R., C. Balague, and D. T. Curiel. 2000. Replicative adenoviruses
for cancer therapy. Nat. Biotechnol. 18:723–727.
3. Bateman, A., F. Bullough, S. Murphy, L. Emiliusen, D. Lavillette, F. L.
Cosset, R. Cattaneo, S. J. Russell, and R. G. Vile. 2000. Fusogenic membrane
glycoproteins as a novel class of genes for the local and immune-mediated
control of tumor growth. Cancer Res. 60:1492–1497.
4. Bischoff, J. R., D. H. Kirn, A. Williams, C. Heise, S. Horn, M. Muna, L. Ng,
J. A. Nye, A. Sampson-Johannes, A. Fattaey, and F. McCormick. 1996. An
adenovirus mutant that replicates selectively in p53-deficient human tumor
cells. Science 274:373–376.
5. Bucheit, A. D., S. Kumar, D. M. Grote, Y. Lin, V. von Messling, R. B.
Cattaneo, and A. K. Fielding. 2003. An oncolytic measles virus engineered to
enter cells through the CD20 antigen. Mol. Ther. 7:62–72.
6. Cattaneo, R. 2004. Four viruses, two bacteria, and one receptor: membrane
cofactor protein (CD46) as pathogens’ magnet. J. Virol. 78:4385–4388.
7. Cullen, B. R. 2001. Journey to the center of the cell. Cell 105:697–700.
8. Dobbelstein, M. 2004. Replicating adenoviruses in cancer therapy. Curr.
Top. Microbiol. Immunol. 273:291–334.
9. Dorig, R. E., A. Marcil, A. Chopra, and C. D. Richardson. 1993. The human
CD46 molecule is a receptor for measles virus (Edmonston strain). Cell
75:295–305.
10. Douglas, J. T., B. E. Rogers, M. E. Rosenfeld, S. I. Michael, M. Feng, and
D. T. Curiel. 1996. Targeted gene delivery by tropism-modified adenoviral
vectors. Nat. Biotechnol. 14:1574–1578.
11. Erlenhofer, C., W. P. Duprex, B. K. Rima, V. ter Meulen, and J. Schneider-
Schaulies. 2002. Analysis of receptor (CD46, CD150) usage by measles virus.
J. Gen. Virol. 83:1431–1436.
12. Fallaux, F. J., O. Kranenburg, S. J. Cramer, A. Houweling, H. Van Ormondt,
R. C. Hoeben, and A. J. Van Der Eb. 1996. Characterization of 911: a new
helper cell line for the titration and propagation of early region 1-deleted
adenoviral vectors. Hum. Gene Ther. 7:215–222.
1916 NOTES J. VIROL.
13. Fritz, B., W. Kuster, K. H. Orstavik, A. Naumova, J. Spranger, and H.
Rehder. 1998. Pigmentary mosaicism in hypomelanosis of Ito. Further evi-
dence for functional disomy of Xp. Hum. Genet. 103:441–449.
14. Galanis, E., A. Bateman, K. Johnson, R. M. Diaz, C. D. James, R. Vile, and
S. J. Russell. 2001. Use of viral fusogenic membrane glycoproteins as novel
therapeutic transgenes in gliomas. Hum. Gene Ther. 12:811–821.
15. Greber, U. F., P. Webster, J. Weber, and A. Helenius. 1996. The role of the
adenovirus protease on virus entry into cells. EMBO J. 15:1766–1777.
16. Greber, U. F., M. Willetts, P. Webster, and A. Helenius. 1993. Stepwise
dismantling of adenovirus 2 during entry into cells. Cell 75:477–486.
17. Hammond, A. L., R. K. Plemper, J. Zhang, U. Schneider, S. J. Russell, and
R. Cattaneo. 2001. Single-chain antibody displayed on a recombinant mea-
sles virus confers entry through the tumor-associated carcinoembryonic an-
tigen. J. Virol. 75:2087–2096.
18. Hawkins, L. K., and T. W. Hermiston. 2001. Gene delivery from the E3
region of replicating human adenovirus: evaluation of the ADP region. Gene
Ther. 8:1132–1141.
19. Hawkins, L. K., and T. W. Hermiston. 2001. Gene delivery from the E3
region of replicating human adenovirus: evaluation of the E3B region. Gene
Ther. 8:1142–1148.
20. Hawkins, L. K., L. Johnson, M. Bauzon, J. A. Nye, D. Castro, G. A. Kitzes,
M. D. Young, J. K. Holt, P. Trown, and T. W. Hermiston. 2001. Gene
delivery from the E3 region of replicating human adenovirus: evaluation of
the 6.7 K/gp19 K region. Gene Ther. 8:1123–1131.
21. He, T. C., S. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein.
1998. A simplified system for generating recombinant adenoviruses. Proc.
Natl. Acad. Sci. USA 95:2509–2514.
22. Higuchi, H., S. F. Bronk, A. Bateman, K. Harrington, R. G. Vile, and G. J.
Gores. 2000. Viral fusogenic membrane glycoprotein expression causes syn-
cytia formation with bioenergetic cell death: implications for gene therapy.
Cancer Res. 60:6396–6402.
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